AMENEH SADEGHPOUR

Key Responsibilities:

• Strategic Direction: Directed Navbit's overarching strategic vision, ensuring sustainable growth and profitability by synthesizing diverse organizational inputs from both domestic and international operations.
• Partnership & Negotiations: Identified, evaluated, and secured potential strategic partnerships, ensuring alignment with Navbit's core objectives and delivering mutually beneficial terms.
• Stakeholder Collaboration: Collaborated with the CEO to sculpt Navbit's global growth blueprint, leveraging empirical analysis to spotlight lucrative growth avenues and steer thecompany's trajectory.
• Investor Relations: Crafted persuasive investment proposals, presenting Navbit's potential to a range of stakeholders, from venture capitalists to private equity firms.
• Risk Management & Business Development: Championed enterprise-wide initiatives aimed at exploring novel business opportunities, while adeptly navigating and mitigating associated risks.

Achievements:

• Capital Acquisition: Orchestrated a successful $11 million funding round, deploying a compelling pitch that resonated with investors.
• Market Expansion: Spearheaded negotiations to ink a distribution agreement with a major medical device company, catalysing Navbit's market expansion, which subsequently doubled revenue.
• Product Launch: Pioneered the launch strategy for a AI-based surgical planning software, achieving a 20% revenue spike within six months, broadening clientele, and fortifying brand presence.

Key Responsibilities:

• Strategic Vision & Leadership: Shaped and drove growth strategies, fostering a shared organisational vision while liaising closely with the CEO and board members.
• Team Management & Collaboration: Piloted three pivotal business units—Innovation, Quality, and Regulatory—overseeing cross-functional teams and spearheading technology solutions for a spectrum of products.
• Stakeholder Engagement: Regularly interfaced with the board, streamlining project structures, budgets, and driving tangible business outcomes.
• Research Collaboration: Established and nurtured partnerships with various research institutions, enhancing Allegra's innovation capacity and technological advancement.

Achievements:

• Pandemic Response: Demonstrated agility by conceptualising and launching an innovative face shield during the COVID-19 pandemic, generating over $1.2M profit within a month.
• Innovation at Forefront: Guided the journey of the world's first bio-ceramic 3D printed spinal implant from its infancy to FDA submission, setting new industry standards. This milestone included licensing pivotal technology from the University of Sydney.
• Research Excellence: Authored and co-authored three notable publications in the med-tech field, amplifying Allegra's presence in academic and professional circles.
• Grant Acquisition: Successfully secured over $4.2M in competitive grants, inclusive of awards from NHMRC Development, IMCRC, MDF, MTPConnect, and Commercialisation grants, to further fuel technological advancements.
• Capital Momentum: Led fundraising campaigns that successfully raised $8M to bolster Allegra's growth and R&D initiatives.

Highlights:

• Global Expansion: Entrusted with and successfully executed the pivotal task of adapting Genea Biomedx's operational model from Australia to the UK. Demonstrated acute understanding of both regional nuances and industry specifics.
• Strategic Leadership: Spearheaded the establishment of a $10M medical devices manufacturing facility in the UK, playing a central role from inception to full-scale operation.
• Talent Acquisition & Management: Successfully recruited a high-calibre team of professionals to establish and manage the new facility, ensuring seamless alignment with corporate objectives and operational benchmarks.
• Operational Excellence: Formulated and implemented robust operational strategies, streamlining manufacturing processes and bolstering productivity, solidifying Genea's presence in the UK market.